I admit there definite differences between the 2 business but is it like comparing an ultrasound to a CAT scan?
RAP claim a pretty high success rate at diagnosing lung disorders. Isn't that what CYC claims to do also? Diagnose lung issues?
Maybe RAP's technology would be a cheap first step to diagnosis then nuclear medicine such as Technegas could be used for a clearer picture - ie 3D scan to assess the extent of the lung damage?
True RAP have no revenue or dividends. They are looking to have FDA approval by Q4.
Don't get me wrong, I'm a fan of both businesses, I'm just having a discussion as they both target lung disorders.
I admit there definite differences between the 2 business but is...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
99.5¢ |
Change
-0.005(0.50%) |
Mkt cap ! $110.5M | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.01 | 99.0¢ | $83.69K | 83.79K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4978 | 99.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.00 | 21625 | 1 |
View Market Depth
| Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
| CYC (ASX) Chart |